BofA Securities resumes CoreWeave stock coverage with buy rating By Investing.com

BofA resumed coverage of CoreWeave (CRWV) with a Buy and $100 price target vs. the current $81.96 share price, implying ~22% upside. The firm cites 168% LTM revenue growth, strong AI compute demand, partnerships with Nvidia/OpenAI and product updates (Nvidia HGX B300) and a planned 300 MW AI data center in Saskatchewan coming H1 next year; valuation noted at 21x CY2027 EV/EBIT vs peer 16x and 28.6x LTM EV/EBITDA. Mixed analyst signals (Oppenheimer Outperform, Bernstein Underperform) plus InvestingPro flagging the stock as overvalued indicate upside is balanced by valuation risk.

Analysis

This is an infrastructure story more than a pure software one: firms that control specialized GPU capacity and the orchestration layer capture a pricing wedge between raw silicon and finished AI service. That wedge can persist while allocations remain lumpy and power/real-estate constraints slow hyperscaler buildouts; expect the revenue/margin profile of well‑run GPU cloud specialists to decouple from general cloud peers for multiple quarters.

Second‑order winners include regional utilities, low-cost power providers, and grid‑scale battery firms that can monetize capacity flexibility and demand response; conversely, commodity GPU spot-rental pools and margin-thin colo operators are vulnerable as customers consolidate around providers offering integrated stack and SLAs. Watch for model efficiency gains (quantization, sparsity, distillation) to act as a multi-quarter dampener on marginal infrastructure consumption — a 20–40% reduction in compute per inference or training pass materially lengthens payback periods for new capacity.

Catalysts that re-rate the group are utilization prints, large multiyear supply contracts, and evidence of sticky software lock-in; tail risks are rapid silicon oversupply, an abrupt funding freeze in AI startups, or permitting/power setbacks for major data centers. Trading outcomes will be binary near term (utilization beats/misses) but mean reversion heavy over 12–24 months where execution and customer concentration decide winners versus those priced for perfection.

Key Decisions for Investors

• Long CRWV (size 2–4% portfolio) with a 12–24 month horizon: enter on strength or on pullback up to 20% from today; target 30–40% upside tied to utilization/multiple expansion, stop at 20–25% downside. R/R ~3:1 if execution and contract wins continue to print.
• Buy-duration asymmetric via options: purchase 12–18 month CRWV LEAPS sized to risk 1% portfolio (e.g., ~50% OTM calls) and finance by selling 100–120% OTM calls further out to cut premium. Max loss = premium (~1% portfolio); upside skew 3–5x if capacity tightness persists.
• Pair trade to hedge semiconductor cyclicality: go long CRWV (3% weight) and short NVDA (1.5% weight) for 6–12 months to isolate infrastructure‑specific re‑rating versus chip‑cyclicality. This reduces market beta; risk is NVDA outperformance — size accordingly and tighten stops if NVDA drives broad sector multiple expansion.
• Tactical income/defensive: add a small position in BCE (1–2% portfolio) for 6–12 months to capture regional connectivity/peering optionality and dividend cushion if local data‑center rollouts accelerate. Expect modest upside (15–20%) plus income; tail risk is regulatory/CapEx execution.